Kolesar Jill M, Sachidanandam Kamakshi, Schelman William R, Eickhoff Jens, Holen Kyle D, Traynor Anne M, Alberti Dona B, Thomas James P, Chitambar Christopher R, Wilding George, Antholine William E
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, 600 Highland Ave., Room K4/554, Madison, WI 53792-5669, United States.
Exp Ther Med. 2011 Jan;2(1):119-123. doi: 10.3892/etm.2010.165.
3-AP (3-aminopyridine-2-carboxaldehyde thiosemicarbazone, 3-AP) is a metal chelator that potently inhibits the enzyme ribonucleotide reductase, RR, which plays a key role in cell division and tumor progression. A sub-unit of RR has a non-heme iron and a tyrosine free radical, which are required for the enzymatic reduction of ribonucleotides to deoxyribonucleotides. The objective of the study was to determine whether 3-AP affects its targeted action by measuring EPR signals formed either directly or indirectly from low molecular weight ferric-3-AP chelates. METHODS: Peripheral blood lymphocytes were collected from patients with refractory solid tumors at baseline and at 2, 4.5 and 22 hours after 3-AP administration. EPR spectra were used to identify signals from high-spin Fe-transferrin, high-spin heme and low-spin iron or copper ions. RESULTS: An increase in Fe-transferrin signal was observed, suggesting blockage of Fe uptake. It is hypothesized that formation of reactive oxygen species by FeT(2) or CuT damage transferrin or the transferrin receptor. An increase in heme signal was also observed, which is a probable source of cytochrome c release from the mitochondria and potential apoptosis. In addition, increased levels of Fe and Cu were identified. CONCLUSION: These results, which were consistent with our earlier study validating 3-AP-mediated signals by EPR, provide valuable insights into the in vivo mechanism of action of 3-AP.
3-氨基吡啶-2-甲醛缩氨基硫脲(3-AP)是一种金属螯合剂,能有效抑制核糖核苷酸还原酶(RR),RR在细胞分裂和肿瘤进展中起关键作用。RR的一个亚基含有一个非血红素铁和一个酪氨酸自由基,这是将核糖核苷酸酶促还原为脱氧核糖核苷酸所必需的。本研究的目的是通过测量由低分子量铁-3-AP螯合物直接或间接形成的电子顺磁共振(EPR)信号,来确定3-AP是否影响其靶向作用。方法:从难治性实体瘤患者中在基线时以及给予3-AP后2小时、4.5小时和22小时采集外周血淋巴细胞。EPR光谱用于识别来自高自旋铁转铁蛋白、高自旋血红素以及低自旋铁或铜离子的信号。结果:观察到铁转铁蛋白信号增加,提示铁摄取受阻。据推测,FeT(2)或CuT产生的活性氧会损伤转铁蛋白或转铁蛋白受体。还观察到血红素信号增加,这可能是细胞色素c从线粒体释放及潜在凋亡的一个来源。此外,还发现铁和铜的水平升高。结论:这些结果与我们早期通过EPR验证3-AP介导信号的研究一致,为3-AP的体内作用机制提供了有价值的见解。